Gufic Biosciences Share Price

₹ 417.00

-₹6.75 (-1.59%)
1D
Last updated 29 Oct, 2026, 15:29 IST
NSE: GUFICBIO
|
Pharmaceuticals

Gufic Biosciences Share Price Today

As of 29 Oct 2026, Gufic Biosciences share price is ₹417.00. The stock opened at ₹423.00, compared to its previous close of ₹423.75. During today's trading session, Gufic Biosciences share price moved in the range of ₹416.25 to ₹424.05, with an average price of ₹420.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹268.00 and a high of ₹467.80.

Share price over the last 1 day fell from 420.75 to 417.00, ranging between 416.40 and 423.20.
₹416.25
1.59% down today
₹424.05
1D LOW
1D HIGH

Gufic Biosciences Stock Insights

Latest Earning
Op Profit TrendUp by 3.77% QoQ
Latest Earning
Net Profit TrendUp by 1.87% QoQ
Latest Earning
Revenue TrendUp by 4.24% QoQ
Stock Performance
OutperformingBeat Nifty by 0.14 % in last 1 month
Shareholding Pattern
DIIDII increased stake by 46.21%
Shareholding Pattern
FIIFII decreased stake by 3.65%
Gufic Biosciences stock performance
Open₹423.00
High₹424.05
Low₹416.25
Prev. close₹423.75
Gufic Biosciences trading activity
Volume26,737
Average traded price₹420.66
Last traded time03:29:58 29 Oct
Last traded quantity5
Circuit
L
H
₹339.00
₹508.50
52-week
L
H
₹268.00
₹467.80
Mkt Cap Cr
4,248.97
P/E
57.88
P/B
6.39
ROA
5.47%
ROE
9.66%
ROCE
11.45%
Quick Ratio
0.92
EV/EBITDA
27.24

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Gufic BioScience outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Gufic BioScience appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Gufic BioScience revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,282.9534.815.0511.19%13.74%17.33%2.3121.32
Divis Laboratories2,53,833.0986.7815.1414.6%15.32%19.56%3.557.29
Torrent Pharmaceuticals1,75,182.2282.649.444.7%11.42%11.37%0.7533.68
Zydus Lifesciences1,16,907.4525.464.318.57%18.59%17.35%0.9115.54
Laurus Labs1,15,616.01108.2722.2710.38%16.77%16.14%0.6856.59
Cipla1,09,870.4038.493.16.6%8.18%10.8%2.520.58
Dr. Reddy's Laboratories1,08,925.7840.392.874.79%7.21%8.58%1.3518.47
Mankind Pharma1,02,583.8845.325.837.82%12.76%14.68%0.7425.11
Aurobindo Pharma93,959.2125.432.496.34%9.25%11.76%1.1511.98
Lupin90,132.4516.244.0214.47%23.76%24.88%1.429.54

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Gufic Biosciences Company Background

ISIN
INE742B01025
Sector Market Cap
₹ 4,248.97 Cr

Gufic Biosciences Limited is an India-based company, which is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates in the pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.

Gufic Biosciences Financial Highlights

  • Revenue: Gufic Biosciences reported revenue of ₹946.67 crore in FY26 vs ₹823.44 crore in FY25. It showed an increase of 14.97% on a yearly basis.
  • Operating Profit: Gufic Biosciences reported an operating profit of ₹86.55 crore in FY26 vs ₹94.14 crore in FY25. It showed a decrease of 8.06% on a year-on-year basis.
  • Net Profit: Gufic Biosciences reported a net profit of ₹64.21 crore in FY26 vs ₹69.65 crore in FY25. It showed a decrease of 7.81% on a yearly basis.

Gufic Biosciences Quarterly Result Highlights

  • Gufic Biosciences reported revenue of ₹261.28 crore in Jun 2026, compared with ₹250.65 crore in Mar 2026, representing an increase of 4.24% on a quarter-on-quarter (QoQ) basis.
  • Gufic Biosciences reported an operating profit of ₹30.04 crore in Jun 2026, compared with ₹28.95 crore in Mar 2026, representing an increase of 3.77% on a quarter-on-quarter (QoQ) basis.
  • Gufic Biosciences reported a profit of ₹22.31 crore in Jun 2026, compared with ₹21.90 crore in Mar 2026, reflecting an increase of 1.87% on a QoQ basis.
  • The earnings per share (EPS) of Gufic Biosciences stood at ₹6.40 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.50%
FII
0.45%
Other DII
0.35%
Retail and other
23.67%
Mutual funds
3.03%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.44%
Mar 20260.42%
Jun 20260.46%
Sep 20260.45%

Gufic Biosciences Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Gufic Biosciences Share Price History

Gufic Biosciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
28 Oct 26
₹420.95 / ₹423.75
+0.78%
27 Oct 26
₹407.45 / ₹420.45
+3.22%
26 Oct 26
₹391.80 / ₹407.35
+3.97%
23 Oct 26
₹398.95 / ₹391.80
-0.56%
Show more

Gufic Biosciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Revenue₹944.01₹819.81₹806.67
Other Income₹2.66₹3.63₹2.18
Total Revenue₹946.66₹823.43₹808.84
Total Expenses₹860.12₹729.29₹693.17
Profit Before Tax₹86.55₹94.14₹115.67
Tax₹22.34₹24.49₹29.54
Profit After Tax₹64.21₹69.65₹86.14
EPS - Basic₹6.40₹6.95₹8.74
EPS - Diluted₹6.40₹6.95₹8.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Profit before tax₹64.21₹69.65₹86.14
Income before WC changes₹151.81₹137.94₹149.82
Change in Assets-₹131.09-₹9.02-₹170.27
Change in Liabilities₹36.26₹16.46₹40.04
Change in WC-₹94.83₹7.44-₹130.23
Cash flow from Operations₹45.14₹122.57-₹7.46
Cash flow from Investing-₹30.96-₹70.78-₹102.39
Cash flow from Financing₹32.29-₹37.20₹82.38
Total Cash Flow₹46.46₹14.59-₹27.47
Cash (Start of the year)₹15.72₹1.14₹28.60
Cash (End of the year)₹62.19₹15.72₹1.14

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Non-Current Assets₹540.26₹544.84₹492.06
Current Assets₹802.12₹624.52₹600.48
Total Assets₹1,342.37₹1,169.36₹1,092.54
Current Liabilities₹517.85₹387.56₹372.05
Net Current Asset₹284.27₹236.97₹228.43
Non-Current Liabilities₹159.54₹180.73₹187.93
Equity Capital₹664.99₹601.08₹532.56
Total Equity & Liabilities₹1,342.37₹1,169.36₹1,092.54

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹940.48₹819.81₹806.67₹690.62
Other Income₹2.58₹3.62₹2.18₹2.57
Total Revenue₹943.06₹823.42₹808.84₹693.19
Total Expenses₹857.57₹728.99₹693.17₹586.47
Profit Before Tax₹85.49₹94.43₹115.67₹106.72
Tax₹22.34₹24.49₹29.54₹27.02
Profit After Tax₹63.15₹69.93₹86.14₹79.70
EPS - Basic₹6.30₹6.97₹8.74₹8.22
EPS - Diluted₹6.30₹6.97₹8.74₹8.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹63.15₹69.93₹86.14₹79.70
Income before WC changes₹150.74₹138.22₹149.82₹136.36
Change in Assets-₹131.13-₹9.08-₹170.27-₹123.21
Change in Liabilities₹36.42₹16.44₹40.04-₹12.05
Change in WC-₹94.71₹7.37-₹130.23-₹135.25
Cash flow from Operations₹44.19₹122.78-₹7.46-₹26.59
Cash flow from Investing-₹30.96-₹71.79-₹102.40-₹190.73
Cash flow from Financing₹32.19-₹37.20₹82.38₹234.31
Total Cash Flow₹45.42₹13.78-₹27.48₹16.99
Cash (Start of the year)₹14.91₹1.13₹28.60₹11.61
Cash (End of the year)₹60.32₹14.91₹1.13₹28.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹541.33₹545.85₹492.07₹397.05
Current Assets₹800.26₹623.78₹600.47₹464.11
Total Assets₹1,341.59₹1,169.63₹1,092.54₹861.16
Current Liabilities₹517.87₹387.53₹372.05₹288.21
Net Current Asset₹282.39₹236.24₹228.42₹175.90
Non-Current Liabilities₹159.54₹180.73₹187.93₹225.14
Equity Capital₹664.18₹601.36₹532.56₹347.81
Total Equity & Liabilities₹1,341.59₹1,169.63₹1,092.54₹861.16
* All values are in INR Crore
Gufic Biosciences market depth
Bid quantityBid priceAsk priceAsk quantity
00418.8102
0000
0000
0000
0000
Total bid quantity0
Total ask quantity102
Gufic Biosciences technical summary
Bearish indicators3
Neutral indicators3
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
55.18
Neutral
ATR (14)
17.88
Neutral
STOCH(9,6)
87.11
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
17.11
Bullish
UO(9)
52.51
Neutral
ROC(12)
4.29
Bullish
WillR(14)
-12.89
Bearish
Period
Simple value
Exponential vaue
5D
407.47
412.61
10D
406.14
409.91
20D
412.99
412.31
50D
420.76
412.66
100D
403.83
396.31
Volume trend — traded volume by day
29 Oct0L
28 Oct1L
27 Oct0L
26 Oct1L
23 Oct1L
22 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Gufic Biosciences
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Gufic Biosciences

Fund name
AUM
Bank of India Business Cycle Fund
0.87%
SBI Healthcare Opportunities Fund
0.69%
Bank of India Small Cap Fund
0.53%

Gufic Biosciences Returns Calculator

Ex-date: 28 Aug 2026

Top Gainers

BSOFT Share Price
₹342.50
+36.4 (+11.89%)
POONAWALLA Share Price
₹441.50
+38.25 (+9.49%)
ZENSARTECH Share Price
₹537.30
+40.3 (+8.11%)
VGUARD Share Price
₹284.85
+20.85 (+7.9%)
SYRMA Share Price
₹1669.00
+106 (+6.78%)
See more

Top Losers

VAIBHAVGBL Share Price
₹158.30
-29.53 (-15.72%)
EQUITASBNK Share Price
₹57.17
-7.96 (-12.22%)
ECLERX Share Price
₹1660.60
-205.6 (-11.02%)
TTML Share Price
₹35.97
-3.26 (-8.31%)
DALBHARAT Share Price
₹1407.90
-66.5 (-4.51%)
See more

Gufic Biosciences Share Price FAQs

Please be aware that Gufic Biosciences stock prices are subject to continuous fluctuations due to various factors.